Angiotensin Receptor Antagonists: all 1,100 studies that test it
Page 9 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 DiabetesCompletedNCT01011062Not applicable
- A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT01007409Phase 1
- Additive Effects of Pravastatin and ValsartanCompletedNCT01004237Phase 4
- Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionStatus unknownNCT00994617Phase 4
- A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersCompletedNCT00991783Phase 1
- A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00991705Phase 1
- Irbesartan Versus Amlodipine: The OBI StudyWithdrawnNCT00987662Phase 4
- Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes MellitusCompletedNCT00982358Phase 4
- Development of Cocktail for Measuring the Activity of Important Cytochrome P450 EnzymesTerminatedNCT00981929Not applicable
- Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I HypertensionCompletedNCT00971165Phase 3
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCompletedNCT00957554Phase 3
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCompletedNCT00956644Phase 3
- Irbesartan and Amlodipine Combination in Controlling Blood PressureCompletedNCT00950066Phase 2
- Efficacy and Safety of Amlodipine and Losartan in Patients With Essential HypertensionCompletedNCT00942344Phase 2
- Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential HypertensionCompletedNCT00940680Phase 3
- Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential HypertensionCompletedNCT00940667Phase 3
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive PatientsCompletedNCT00939588Phase 2
- A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersCompletedNCT00938197Phase 1
- A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersCompletedNCT00938132Phase 1
- Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersCompletedNCT00937534Phase 1
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedNCT00933231Phase 3
- Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis CWithdrawnNCT00930995Phase 2
- The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
- Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsCompletedNCT00923611Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT00923533Phase 1
- The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With HypertensionCompletedNCT00921570Phase 4
- Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic NephropathyCompletedNCT00914524Phase 2
- Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart FailureCompletedNCT00913653Phase 2
- Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific MealCompletedNCT00905333Phase 1
- Candesartan Versus Propranolol for Migraine PreventionCompletedNCT00884663Phase 2/3
- Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung CancerWithdrawnNCT00880386Not applicable
- Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic StrokeStatus unknownNCT00874601Phase 4
- Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00872586Phase 3
- Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNCT00863980Not applicable
- The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent ProteinuriaStatus unknownNCT00858299Phase 4
- The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)CompletedNCT00856960Phase 1
- Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential HypertensionCompletedNCT00856271Phase 3
- Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese PopulationCompletedNCT00847834Phase 4
- Bioequivalence Study in Healthy SubjectsCompletedNCT00844324Phase 1
- Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureTerminatedNCT00843154Phase 3
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy SubjectsCompletedNCT00839683Phase 1
- Renin Profiling in Selection of Initial Antihypertensive DrugCompletedNCT00834600Not applicable
- Reducing the Overall Risk Level in Patients Suffering From Metabolic SyndromeCompletedNCT00821574Phase 4
- Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With TreatmentStatus unknownNCT00813722Phase 4
- Morning Hypertension and Preminent Therapy StudyCompletedNCT00795847Phase 4
- Saving Residual Renal Function Among Haemodialysis Patients Receiving IrbesartanCompletedNCT00791830Phase 3
- Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)Status unknownNCT00790946Phase 4
- Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockersCompletedNCT00782327Phase 3
- Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.CompletedNCT00775840Phase 3
- Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
- Adiponectin and Insulin Resistance in Diabetic NephropathyCompletedNCT00774904Not applicable
- Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan SyndromeTerminatedNCT00763893Phase 3
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
- Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedNCT00759551Phase 2
- The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)CompletedNCT00754429Phase 4
- Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.CompletedNCT00750113Phase 4
- Regression of Fatty Heart by Valsartan TherapyWithdrawnNCT00745953Phase 4
- Role of AT1-receptor Blockers in Insulin-induced Vasodilation.Status unknownNCT00742066Not applicable
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedNCT00741585Phase 4
- Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With NephropathyCompletedNCT00738660Phase 3
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?Status unknownNCT00732966Not applicable
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)Status unknownNCT00732407Not applicable
- Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis PatientsCompletedNCT00721773Not applicable
- Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.CompletedNCT00720577Early Phase 1
- Telmisartan Versus Ramipril After Acute Coronary SyndromeStatus unknownNCT00702936Phase 4
- The Potential of Candesartan to Retard the Progression of Aortic StenosisStatus unknownNCT00699452Phase 3
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ DamageCompletedNCT00687206Phase 4
- Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan PatientsStatus unknownNCT00683124Phase 3
- Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedNCT00676845Phase 3
- Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCompletedNCT00670566Phase 4
- Losartan and Simvastatin in Hypertensive Obeses With Liver SteatosisStatus unknownNCT00669435Phase 4
- Effects of Losartan on Insulin Resistance in Patients With Heart FailureCompletedNCT00663377Phase 4
- Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left VentricularStatus unknownNCT00659451Phase 3
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00649623Phase 1
- Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00648219Phase 1
- The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus SyndromeStatus unknownNCT00647257Not applicable
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)CompletedNCT00634712Phase 3
- Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)CompletedNCT00634400Phase 3
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)CompletedNCT00634309Phase 3
- Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal InsufficiencyTerminatedNCT00630708Not applicable
- Blood Pressure Lowering in Acute Stroke Trial (BLAST)WithdrawnNCT00627991Not applicable
- Irbesartan and Adhesion Molecules in AFStatus unknownNCT00613496Phase 4
- The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)CompletedNCT00607035Phase 4
- Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With LosartanCompletedNCT00602004Not applicable
- Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in DiabetesCompletedNCT00599885Phase 4
- Losartan Versus Atenolol for the Treatment of Marfan SyndromeCompletedNCT00593710Phase 2
- Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting StentCompletedNCT00589732Phase 4
- Angiotensin-II Blockade in Mitral RegurgitationCompletedNCT00587470Phase 4
- Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3Status unknownNCT00565396Not applicable
- Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeCompletedNCT00564187Phase 4
- Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus LercanidipineStatus unknownNCT00564057Phase 4
- Nt-proBNP Guided Primary Prevention of CV Events in Diabetic PatientsCompletedNCT00562952Phase 2/3
- The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild HypertensionCompletedNCT00562809Phase 4
- Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With MicroalbuminuriaCompletedNCT00561964Phase 3
- Adiponectin in Obese Women With T2DN and Effects by RAS BlockerCompletedNCT00561704Not applicable
- Regulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsCompletedNCT00560430Phase 3
- Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood VesselsTerminatedNCT00559286Phase 4
- To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00550095Phase 4
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCompletedNCT00549133Phase 4